Here’s Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the 10 Best Penny Stocks to Buy for Long Term.

On May 12, 2026, Stifel raised the firm’s price target on AbCellera Biologics Inc. (NASDAQ:ABCL) to $8 from $7 and kept a Buy rating on the shares. The firm said preliminary safety, pharmacokinetic, and pharmacodynamic data from the single-ascending dose portion of the Phase 1 dose-escalation trial evaluating ABCL635 represent an important early step in de-risking the program longer term.

On May 11, 2026, AbCellera Biologics Inc. (NASDAQ:ABCL) reported Q1 EPS of (14c), versus the consensus estimate of (20c). Revenue totaled $8.3M, versus the consensus estimate of $5.8M. Founder and CEO Carl Hansen said interim Phase 1 data showed ABCL635 achieved strong NK3R target engagement at well-tolerated dose levels in healthy volunteers, alongside a pharmacokinetic profile that may support once-monthly dosing. Hansen added that the company expects a Phase 2 efficacy readout in Q3, which management believes could further de-risk the program.

Here's Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term

Management also said that throughout 2026, the company plans to deliver additional clinical data readouts, advance ABCL688 and ABCL386 into IND-enabling studies, and select at least one additional development candidate. AbCellera ended the quarter with approximately $655M in available liquidity.

AbCellera Biologics Inc. (NASDAQ:ABCL) develops antibody-based medicines targeting diseases with unmet medical needs.

While we acknowledge the risk and potential of ABCL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ABCL and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1